NeoGenomics (NEO) Peer Comparison
$19.12
$1.75
(10.07%)
As on 27-Aug-2026 14:36EDT
Market cap
$2,182 Mln
Revenue (TTM)
$766 Mln
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Edit
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,182 | 11,869 | 10,461 | 7,065 | 7,433 |
Revenue ($ Mln) |
766 | 6,206 | 5,487 | 2,595 | 2,578 |
Net Profit ($ Mln) |
-51.88 | 621.00 | 378.70 | 274.99 | -142.03 |
Net Margin (%) |
-6.77 | 10.01 | 6.90 | 10.60 | -5.51 |
RoE (%) |
-6.40 | 16.23 | 16.18 | 30.39 | -32.84 |
Price to Earnings |
-- | 20.19 | 28.18 | 26.88 | -- |
Price-To-Book |
2.78 | 4.59 | 4.29 | 8.42 | 22.38 |
Income Statement ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
766.30 | 6,206.10 | 5,486.71 | 2,595.00 | 2,578.11 |
|
Cost of Revenue
|
437.40 | 1,733.50 | 4,710.80 | 1,805.04 | 910.53 |
|
Gross Profit
|
282.54 | 5,680.80 | 799.45 | 758.34 | 1,733.38 |
|
Operating Expenses
|
395.07 | 3,421.70 | 308.52 | 440.80 | 1,760.25 |
|
Operating Profit (EBIT)
|
-66.17 | 1,117.00 | 467.39 | 349.19 | -92.67 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-54.55 | 1,027.90 | 498.93 | 369.16 | -163.61 |
|
Provision for Tax
|
-2.67 | 210.30 | 119.90 | 94.17 | -21.58 |
|
Profit after Tax (Net Income)
|
-51.88 | 621.00 | 378.70 | 274.99 | -142.03 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 271.90 | 0.00 | 140.99 | 0.00 |
Liabilities ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
785.73 | 2,597.70 | 2,441.69 | 830.51 | 324.07 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
459.77 | 3,123.00 | 2,419.29 | 429.23 | 1,821.51 |
|
Current Liabilities
|
105.88 | 873.40 | 884.80 | 319.85 | 1,483.23 |
|
Total Liabilities
|
1,359.83 | 7,089.70 | 5,462.97 | 1,640.01 | 2,154.71 |
Assets ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
970.77 | 6,416.50 | 4,677.91 | 1,288.35 | 2,244.20 |
|
Current Assets
|
381.48 | 1,041.00 | 1,071.49 | 291.24 | 1,384.61 |
|
Total Assets
|
1,359.83 | 7,089.70 | 5,462.97 | 1,640.01 | 2,154.71 |
|
Total Debt*
|
448.37 | 2,842.30 | 2,250.35 | 329.09 | 1,546.24 |
|
Net Current Assets
|
275.60 | 167.60 | 186.69 | 0.00 | 0.00 |
Cashflow ($ Mln)
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
5.23 | 1,175.60 | 564.27 | 388.27 | 300.01 |
|
Cash Flow from Investing Activities
|
-12.34 | -762.80 | -513.18 | -59.34 | -1,024.96 |
|
Cash from Financing Activities
|
-200.29 | -433.00 | -11.81 | -432.77 | 729.62 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-7.67 | 11.40 | 6.75 | 22.16 | 11.94 |
|
ROE (%)
|
-6.40 | 16.23 | 16.18 | 30.39 | -32.84 |
|
ROA (%)
|
-3.51 | 7.77 | 6.15 | 14.28 | -3.97 |
|
EBIT Margin (%)
|
-6.86 | 18.59 | 9.24 | 14.08 | -6.35 |
|
Net Margin (%)
|
-6.77 | 10.01 | 6.90 | 10.60 | -5.51 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.19 | 9.47 | 18.89 | 3.31 | 28.04 |
|
EBIT Growth (%)
|
47.24 | 16.43 | 17.37 | -6.25 | -217.51 |
|
Net Profit Growth (%)
|
50.14 | 18.81 | 17.32 | -5.29 | -173.36 |
|
EPS Growth (%)
|
50.48 | 20.05 | 15.72 | 1.50 | -179.07 |
|
Book Value Growth (%)
|
-10.02 | 16.44 | 19.22 | -24.60 | -36.19 |
Valuation Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-2.80 | 19.12 | 30.03 | 22.57 | 62.76 |
|
Price / Book Value
|
0.36 | 4.44 | 4.63 | 6.11 | 14.89 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-15.90 | 9.54 | 24.49 | 14.37 | 48.19 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.48 | 1.00 | 0.06 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | 0.02 | 0.05 | 0.09 | 0.04 |
|
Current Ratio
|
3.60 | 1.19 | 1.21 | 0.91 | 0.93 |
|
Quick Ratio
|
3.35 | 1.19 | 1.21 | 0.89 | 0.87 |
|
Interest Coverage
|
-20.13 | 9.18 | 65.04 | 77.54 | -- |
Operating Efficiency Ratios
| NeoGenomics (NEO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.89 | 11.07 | 12.19 | 7.27 | 14.56 |
|
Asset Turnover
|
0.52 | 0.78 | 0.89 | 1.35 | 0.72 |
|
Receivable days
|
77.78 | 37.48 | 43.58 | 25.53 | 2.97 |
|
Inventory Days
|
22.71 | -- | -- | 1.62 | 53.56 |
|
Payable days
|
18.35 | 250.68 | 8.42 | 10.06 | 69.71 |
|
Cash Conversion Cycle
|
82.14 | -- | -- | 17.10 | -13.17 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
